SIGNATUREFD, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,592
-7.9%
841
+18.8%
0.00%0.0%
Q2 2023$28,872
-2.2%
708
-10.6%
0.00%0.0%
Q1 2023$29,518
+166.0%
792
+149.1%
0.00%
Q4 2022$11,095
-38.4%
318
+1.0%
0.00%
-100.0%
Q3 2022$18,000
+20.0%
315
+9.0%
0.00%0.0%
Q2 2022$15,000
-21.1%
289
+11.6%
0.00%0.0%
Q1 2022$19,000
-44.1%
259
-9.1%
0.00%0.0%
Q4 2021$34,000
-5.6%
285
+4.8%
0.00%0.0%
Q3 2021$36,000
-29.4%
272
-13.7%
0.00%
-50.0%
Q2 2021$51,000
+82.1%
315
-10.0%
0.00%
+100.0%
Q1 2021$28,000
+100.0%
350
+40.0%
0.00%0.0%
Q4 2020$14,000
+366.7%
250
+55.3%
0.00%
Q3 2020$3,000
+50.0%
161
+61.0%
0.00%
Q2 2020$2,000
-60.0%
100
-76.9%
0.00%
Q1 2020$5,000
+150.0%
432
+319.4%
0.00%
Q4 2019$2,000
+100.0%
1030.0%0.00%
Q3 2019$1,000
-50.0%
1030.0%0.00%
Q2 2019$2,0000.0%1030.0%0.00%
Q1 2019$2,000
+100.0%
103
+3.0%
0.00%
Q4 2018$1,000
-66.7%
1000.0%0.00%
Q3 2018$3,000
-80.0%
100
-81.8%
0.00%
-100.0%
Q2 2018$15,000
+66.7%
550
+22.2%
0.00%
+100.0%
Q1 2018$9,0004500.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders